Nurtec Odt Tablet, Orally Disintegrating
Product Images NDC 72618-3001

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Nurtec Odt (NDC 72618-3001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nurtec 01

NURTEC ODT 75 mg orally disintegrating tablet packaging label. The product contains the active ingredient rimegepant sulfate in a 75 mg strength. The label displays the Pfizer Laboratories division of Pfizer Inc as the labeler. The image shows the front of the tablet carton with dosage form and strength clearly marked.*

FDA Label Image

Nurtec 02

Chemical structure diagram of the active ingredient rimegepant sulfate, showing its molecular composition including sulfate and hydrate components, corresponding to the 75 mg strength of NURTEC ODT orally disintegrating tablets.*

FDA Label Image

Nurtec 03

A line graph depicting the percent of subjects achieving pain freedom over time, comparing NURTEC ODT 75 mg tablets and placebo. The x-axis represents time in hours from dose (0 to 2 hours), and the y-axis shows the percent achieving pain freedom (0% to 100%). NURTEC ODT 75 mg shows a higher percentage than placebo at each time point after dosing.*

FDA Label Image

Nurtec 04

A line graph comparing the percentage of subjects achieving MBS freedom over time between NURTEC ODT 75 mg and placebo. The x-axis shows time in hours from dose (0 to 2 hours), and the y-axis shows percent achieving MBS freedom (0% to 100%). Two lines represent NURTEC ODT 75 mg and placebo, with NURTEC ODT showing higher percentages throughout the time points.*

FDA Label Image

Nurtec 05

A line graph comparing the change from baseline in monthly migraine days over three months between placebo and rimegepant 75 mg. The Y-axis represents change from baseline in monthly migraine days, and the X-axis represents time points: baseline, month 1, month 2, and month 3. Data points with error bars are shown for both treatment groups, with rimegepant 75 mg demonstrating a greater reduction over time than placebo.*

FDA Label Image

Nurtec 06

A bar chart comparing the percentage of patients with reductions in migraine days per month between placebo and rimegepant 75 mg groups. The horizontal axis shows ranges of migraine day reductions, and the vertical axis shows the percent of patients. Data indicates higher patient percentages with migraine reductions in the rimegepant group compared to placebo across most categories.*

FDA Label Image

Nurtec 07

NURTEC ODT 75 mg orally disintegrating tablets packaging label. The front of the blister card shows ten tablets arranged in two rows of five, with alternating blue and white coloring. The label includes the generic name rimegepant sulfate, strength 75 mg, and manufacturer Pfizer Laboratories Div Pfizer Inc. The packaging is designed for prescription use.*

FDA Label Image

Nurtec 10

NURTEC ODT 75 mg orally disintegrating tablets packaging label showing the labeler Pfizer Laboratories Div Pfizer Inc. The label includes storage instructions, usage directions, dosage information, and manufacturer details from Biohaven Pharmaceuticals, Inc. The package contains 8 tablets of rimegepant sulfate in orally disintegrating tablet form. The label features a multicolor design with purple and teal accents and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.